
Mymedrica Private Limited
Founded in 2016 and headquartered in Maharashtra, India.
Founded in 2016 and headquartered in Maharashtra, India.
Jalgaon, Maharashtra, India
+91-XXXXXXXXXX
U63000MH2016PTC273415
273415
Private Limited Indian Non-Government Company
23 Feb 2016
23 Sep 2016
31 Mar 2016
Unlisted
Roc Mumbai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Neetika Jain ![]() | Director | 23-Feb-2016 | Current |
Ishwarlal Shankarlal ![]() | Director | 23-Feb-2016 | Current |
Enhance accessibility to Mymedrica's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
In 2016, Mymedrica had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Neetika Jain and Ishwarlal Shankarlal are mutual person
Neetika Jain and Ishwarlal Shankarlal are mutual person
Neetika Jain and Ishwarlal Shankarlal are mutual person
Neetika Jain and Ishwarlal Shankarlal are mutual person
Neetika Jain and Ishwarlal Shankarlal are mutual person
Neetika Jain is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Mymedrica, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Mymedrica, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mymedrica's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Mymedrica Private Limited last Annual general meeting of members was held on 23 Sep 2016 as per latest MCA records.
Mymedrica Private Limited has filed its annual Financial statements for the year ended 31 Mar 2016 with Roc Mumbai.
Neetika Manish Jain was appointed as a Director was appointed as a Director on 23 Feb 2016 & has been associated with this company since 9 years 2 months .
Ishwarlal Jain Shankarlal was appointed as a Director was appointed as a Director on 23 Feb 2016 & has been associated with this company since 9 years 2 months .
Mymedrica Private Limited was registered on 23 Feb 2016 with Roc Mumbai & aged 9 years 2 months as per MCA records.
Mymedrica Private Limited was incorporated on 23 Feb 2016.
The authorized share capital of Mymedrica Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Mymedrica Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Mymedrica Private Limited is 189, Saraf Bazar, Jalgaon, Maharashtra, India, 425001.
The corporate identification number (CIN) of Mymedrica Private Limited is U63000MH2016PTC273415 and the company number is 273415 as per Ministry of Corporate Affairs (MCA).
The most recent Balance Sheet for Mymedrica Private Limited was filed with the ROC on 31 Mar 2016.
Search company & director profiles for free and gain access to critical business data.